DEXCOM, INC. Fair Value of Long-Term Debt
DEXCOM, INC. (DXCM) had Fair Value of Long-Term Debt of $409.70 million as of 2017-06-30, per its 10-Q filed 2017-08-01.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:LongTermDebtFairValue · last filed 2017-11-01
- 2017-06-30: Long-term Debt, Fair Value $409.70M.
- 2016-12-31: Long-term Debt, Fair Value $0.00.
| Period end | Long-term Debt, Fair Value |
|---|---|
| 2017-06-30 | $409.70M 10-Q · filed 2017-08-01 |
| 2016-12-31 | $0.00 10-Q · filed 2017-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |